Pour pallier ces limitations, un certain nombre dapproches pharmacologiques ont t dveloppes au cours des dernires dcennies, mais ces mdicaments sont gnralement dune efficacit assez limite, coteux et peuvent causer dans certains cas des effets secondaires importants
if pancreatitis is suspected, do not take any further doses and seek urgent medical assessment immediately [15] [16] Pain in the upper right abdomen, or yellowing of the skin or whites of the eyes (jaundice) these may indicate gallbladder disease, a risk associated with rapid weight loss and GLP-1 receptor agonist use [16] [17] Fever accompanying diarrhoea, which may suggest an infective cause requiring separate investigation Significant unintentional weight loss beyond what is expected from the treatment For people with type 2 diabetes: persistent diarrhoea can reduce carbohydrate absorption and increase the risk of hypoglycaemia, particularly if insulin or sulphonylureas are co-prescribed
and the 2025 Monitoring Program, which includes substances that are not on the List, but that WADA wishes to monitor in order to detect potential patterns of misuse in sport
Broad-Use Case Standouts : Yaoling Biotechnology (Guangzhou) Co., Ltd
